Similar articles

• The clinical use of class IC antiarrhythmic drugs.

  Abi Samra F. Abi Samra F. J La State Med Soc. 1989 May;141(5):27-31. J La State Med Soc. 1989. PMID: 2499646 Review.
• Flecainide and CAST.

  [No authors listed] [No authors listed] Lancet. 1989 Aug 26;2(8661):481-2. Lancet. 1989. PMID: 2570188 Clinical Trial. No abstract available.
• Encainide and flecainide in children: separating the wheat from the chaff.

  Perry JC, Garson A Jr. Perry JC, et al. J Am Coll Cardiol. 1991 Aug;18(2):366-7. doi: 10.1016/0735-1097(91)90587-y. J Am Coll Cardiol. 1991. PMID: 1906903 No abstract available.
• An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial.

  Coyle JD, Schaal SF. Coyle JD, et al. DICP. 1989 Jun;23(6):478-9. doi: 10.1177/106002808902300609. DICP. 1989. PMID: 2500783 Clinical Trial. No abstract available.
• CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

  Akhtar M, Breithardt G, Camm AJ, Coumel P, Janse MJ, Lazzara R, Myerburg RJ, Schwartz PJ, Waldo AL, Wellens HJ, et al. Akhtar M, et al. Circulation. 1990 Mar;81(3):1123-7. doi: 10.1161/01.cir.81.3.1123. Circulation. 1990. PMID: 1689621 Review. No abstract available.